Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Zhenjiang Probio Biotech Co. Ltd. has 1 pending office action currently active. This prosecution is handled by 1 distinct examiner, BARRON, SEAN C. The data indicates that 0 distinct art units are associated with this portfolio, which may reflect a specific administrative classification.
The busiest examiner, BARRON, SEAN C, is responsible for 1 busiest examiner pending action. This single action represents the entirety of the company's current pending workload of 1 action. Because the prosecution is concentrated under 1 distinct examiner, the company's strategy is focused on a single point of contact. The progress of the pending matter depends entirely on the review of BARRON, SEAN C, with no other examiners currently involved in the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARRON, SEAN C | 1 | 52.9% | +30.9% |
| ABBOTT, KODYE LEE | 1 | 53.1% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700983 | HEK293 CELL LINE ADAPTED TO SERUM-FREE SUSPENSION CULTURE AND USE THEREOF | BARRON, SEAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700983 | HEK293 CELL LINE ADAPTED TO SERUM-FREE SUSPENSION CULTURE AND USE THEREOF | BARRON, SEAN C | — |
| 18257802 | HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR | ABBOTT, KODYE LEE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18700983 | HEK293 CELL LINE ADAPTED TO SERUM-FREE SUSPENSION CULTURE AND USE THEREOF | BARRON, SEAN C | — | §101§102§103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18257802 | HEK293T CELL STRAIN HAVING HIGH DISPERSIBILITY AND SCREENING METHOD THEREFOR | ABBOTT, KODYE LEE | 1634 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial